Bionano Genomics Statistics
Total Valuation
BNGO has a market cap or net worth of $13.31 million. The enterprise value is $15.59 million.
| Market Cap | 13.31M |
| Enterprise Value | 15.59M |
Important Dates
The last earnings date was Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BNGO has 11.09 million shares outstanding. The number of shares has increased by 335.79% in one year.
| Current Share Class | 11.09M |
| Shares Outstanding | 11.09M |
| Shares Change (YoY) | +335.79% |
| Shares Change (QoQ) | +6.66% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 12.25% |
| Float | 9.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| Forward PS | 0.38 |
| PB Ratio | 0.35 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.45.
| Current Ratio | 1.84 |
| Quick Ratio | 0.87 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -109.97 |
Financial Efficiency
Return on equity (ROE) is -73.78% and return on invested capital (ROIC) is -33.83%.
| Return on Equity (ROE) | -73.78% |
| Return on Assets (ROA) | -28.60% |
| Return on Invested Capital (ROIC) | -33.83% |
| Return on Capital Employed (ROCE) | -75.20% |
| Weighted Average Cost of Capital (WACC) | 6.49% |
| Revenue Per Employee | $296,268 |
| Profits Per Employee | -$325,732 |
| Employee Count | 97 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.05 |
Taxes
In the past 12 months, BNGO has paid $70,000 in taxes.
| Income Tax | 70,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.80% in the last 52 weeks. The beta is 1.63, so BNGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | -68.80% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 42.23 |
| Average Volume (20 Days) | 183,269 |
Short Selling Information
The latest short interest is 1.22 million, so 11.04% of the outstanding shares have been sold short.
| Short Interest | 1.22M |
| Short Previous Month | 1.13M |
| Short % of Shares Out | 11.04% |
| Short % of Float | 12.29% |
| Short Ratio (days to cover) | 8.00 |
Income Statement
In the last 12 months, BNGO had revenue of $28.74 million and -$31.60 million in losses. Loss per share was -$4.21.
| Revenue | 28.74M |
| Gross Profit | 13.50M |
| Operating Income | -32.77M |
| Pretax Income | -31.53M |
| Net Income | -31.60M |
| EBITDA | -23.37M |
| EBIT | -32.77M |
| Loss Per Share | -$4.21 |
Balance Sheet
The company has $14.41 million in cash and $17.01 million in debt, with a net cash position of -$2.61 million or -$0.24 per share.
| Cash & Cash Equivalents | 14.41M |
| Total Debt | 17.01M |
| Net Cash | -2.61M |
| Net Cash Per Share | -$0.24 |
| Equity (Book Value) | 37.46M |
| Book Value Per Share | 3.32 |
| Working Capital | 17.75M |
Cash Flow
| Operating Cash Flow | -19.30M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 9.40M |
| Net Borrowing | -3.45M |
| Free Cash Flow | -19.30M |
| FCF Per Share | -$1.74 |
Margins
Gross margin is 46.97%, with operating and profit margins of -114.03% and -109.95%.
| Gross Margin | 46.97% |
| Operating Margin | -114.03% |
| Pretax Margin | -109.70% |
| Profit Margin | -109.95% |
| EBITDA Margin | -81.31% |
| EBIT Margin | -114.03% |
| FCF Margin | n/a |
Dividends & Yields
BNGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -335.79% |
| Shareholder Yield | -335.79% |
| Earnings Yield | -243.47% |
| FCF Yield | -148.70% |
Analyst Forecast
The average price target for BNGO is $5.00, which is 316.67% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.00 |
| Price Target Difference | 316.67% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 24.33% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 1:60.
| Last Split Date | Jan 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:60 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |